FDA accused of not pursuing leads in heparin case

Posted April 30, 2010 at 10:24 a.m.

From The Wall Street Journal | A Congressional committee faulted the Food and Drug Administration for not pursuing “specific and credible leads” to identify culprits in China during the 2008 crisis involving contaminated imported heparin.

Get the full story: wsj.com.

Read more about the topics in this post:

Comments are closed.